Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06387173 · ClinicalTrials.gov registry record
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
A clinical trial of Early Stage Breast Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- 2
- Enrollment target
- 1
- Study location
NCT06387173: Active study of Early Stage Breast Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
NCT06387173 is a study of Early Stage Breast Carcinoma that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 2 participants, below the 454-participant average among 4 other Early Stage Breast Carcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06387173, a study of Early Stage Breast Carcinoma, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.
Primary Outcome
record follow up of symptoms, reported complications, breast imaging findings, and results of any future biopsies related to cancer, and treatment of breast cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2099-01-03 |
What the registry record for NCT06387173 still lists
NCT06387173 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 454-participant average among 4 other Early Stage Breast Carcinoma trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Early Stage Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06387173 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06387173 about?
NCT06387173 is a clinical study titled "Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer". This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.
What is the current status of trial NCT06387173?
This trial is currently active not recruiting. The enrollment target is 2 participants. The study started on 2024-01-04. Estimated completion is 2099-01-03.
What conditions does trial NCT06387173 study?
This clinical trial studies the following conditions: Early Stage Breast Carcinoma.
What interventions are being tested in trial NCT06387173?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06387173?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06387173 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Stage Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
RECRUITING · Phase 3
-
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
RECRUITING · Phase 2
-
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
RECRUITING
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI